Diabetic Retinopathy
Lloyd Paul Aiello(Joslin Diabetes Center), Ronald Klein(University of Wisconsin–Madison), George L. King(Joslin Diabetes Center), Jerry D. Cavallerano, Thomas W. Gardner(University of Michigan), George W. Blankenship, Fredrick L Ferris
Cited by 505
Related Papers
Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis
|The Lancet Global Health|2014|5.2k
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Retinopathy in Diabetes
|Diabetes Care|2004|1.1k